Annual Accounts Payable
$514.00 K
-$104.00 K-16.83%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual accounts payable is $514.00 thousand, with the most recent change of -$104.00 thousand (-16.83%) on December 31, 2023.
- During the last 3 years, MTNB annual accounts payable has risen by +$164.10 thousand (+46.90%).
- MTNB annual accounts payable is now -45.14% below its all-time high of $937.00 thousand, reached on December 31, 2021.
Performance
MTNB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$349.00 K
+$111.00 K+46.64%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly accounts payable is $349.00 thousand, with the most recent change of +$111.00 thousand (+46.64%) on September 30, 2024.
- Over the past year, MTNB quarterly accounts payable has dropped by -$486.00 thousand (-58.20%).
- MTNB quarterly accounts payable is now -74.18% below its all-time high of $1.35 million, reached on March 31, 2022.
Performance
MTNB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MTNB Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.8% | -58.2% |
3 y3 years | +46.9% | -58.2% |
5 y5 years | +73.8% | -58.2% |
MTNB Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -45.1% | at low | -74.2% | +46.6% |
5 y | 5-year | -45.1% | +46.9% | -74.2% | +46.6% |
alltime | all time | -45.1% | +89.5% | -74.2% | +66.6% |
Matinas BioPharma Holdings Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $349.00 K(+46.6%) |
Jun 2024 | - | $238.00 K(-49.7%) |
Mar 2024 | - | $473.00 K(-8.0%) |
Dec 2023 | $514.00 K(-16.8%) | $514.00 K(-38.4%) |
Sep 2023 | - | $835.00 K(+38.2%) |
Jun 2023 | - | $604.00 K(+17.1%) |
Mar 2023 | - | $516.00 K(-16.5%) |
Dec 2022 | $618.00 K(-34.0%) | $618.00 K(-5.9%) |
Sep 2022 | - | $656.70 K(+32.1%) |
Jun 2022 | - | $497.20 K(-63.2%) |
Mar 2022 | - | $1.35 M(+44.3%) |
Dec 2021 | $937.00 K(+167.8%) | $937.00 K(+41.5%) |
Sep 2021 | - | $662.00 K(+46.9%) |
Jun 2021 | - | $450.50 K(+6.9%) |
Mar 2021 | - | $421.60 K(+20.5%) |
Dec 2020 | $349.90 K(-48.5%) | $349.90 K(-6.2%) |
Sep 2020 | - | $373.10 K(-24.6%) |
Jun 2020 | - | $494.60 K(-48.1%) |
Mar 2020 | - | $953.30 K(+40.3%) |
Dec 2019 | $679.30 K | $679.30 K(-0.9%) |
Sep 2019 | - | $685.80 K(+25.1%) |
Jun 2019 | - | $548.10 K(+38.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $394.70 K(+33.5%) |
Dec 2018 | $295.70 K(-49.3%) | $295.70 K(-2.5%) |
Sep 2018 | - | $303.40 K(-39.0%) |
Jun 2018 | - | $497.40 K(+5.0%) |
Mar 2018 | - | $473.50 K(-18.8%) |
Dec 2017 | $582.90 K(+22.6%) | $582.90 K(+70.6%) |
Sep 2017 | - | $341.60 K(-24.6%) |
Jun 2017 | - | $453.20 K(-63.7%) |
Mar 2017 | - | $1.25 M(+162.3%) |
Dec 2016 | $475.60 K(-4.5%) | $475.60 K(+127.0%) |
Sep 2016 | - | $209.50 K(-56.0%) |
Jun 2016 | - | $475.90 K(-23.3%) |
Mar 2016 | - | $620.60 K(+24.7%) |
Dec 2015 | $497.80 K(+83.6%) | $497.80 K(+76.5%) |
Sep 2015 | - | $282.10 K(-62.2%) |
Jun 2015 | - | $745.60 K(+59.8%) |
Mar 2015 | - | $466.60 K(+72.1%) |
Dec 2014 | $271.20 K(-31.7%) | $271.20 K(+28.0%) |
Sep 2014 | - | $211.80 K(-24.7%) |
Jun 2014 | - | $281.10 K(+16.0%) |
Mar 2014 | - | $242.30 K(-38.9%) |
Dec 2013 | $396.80 K | $396.80 K |
FAQ
- What is Matinas BioPharma Holdings annual accounts payable?
- What is the all time high annual accounts payable for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual accounts payable year-on-year change?
- What is Matinas BioPharma Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly accounts payable year-on-year change?
What is Matinas BioPharma Holdings annual accounts payable?
The current annual accounts payable of MTNB is $514.00 K
What is the all time high annual accounts payable for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual accounts payable is $937.00 K
What is Matinas BioPharma Holdings annual accounts payable year-on-year change?
Over the past year, MTNB annual accounts payable has changed by -$104.00 K (-16.83%)
What is Matinas BioPharma Holdings quarterly accounts payable?
The current quarterly accounts payable of MTNB is $349.00 K
What is the all time high quarterly accounts payable for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly accounts payable is $1.35 M
What is Matinas BioPharma Holdings quarterly accounts payable year-on-year change?
Over the past year, MTNB quarterly accounts payable has changed by -$486.00 K (-58.20%)